Test Price
2,800 AEDโ Home Collection Available
IGHMBP2 Gene Distal Hereditary Motor Neuropathy Type 6 (dHMN6/SMARD1) Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
Compliance & Service Highlights
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified NGS & confirmatory testing.
- Premium Logistics: Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-licensed clinical geneticists.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
- Data Protection: Complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
Test Overview & Methodology
This comprehensive next-generation sequencing (NGS) test analyzes the entire coding region and flanking intronic boundaries of the IGHMBP2 gene, associated with autosomal recessive distal hereditary motor neuropathy type 6 (dHMN6) and severe spinal muscular atrophy with respiratory distress type 1 (SMARD1). It is indicated for individuals with clinical features of distal motor weakness, suspected hereditary neuropathy, or a family history of IGHMBP2-related disorders.
| Feature | Our Test (DNA Labs UAE) | Closest Alternative (Conventional Sanger) |
|---|---|---|
| Precision | High-coverage NGS (>100x) with CNV detection, Sanger confirmation of all pathogenic/likely pathogenic variants | Targeted Sanger sequencing of selected exons, may miss deep intronic or copy number changes |
| Method | NGS (Agilent SureSelect/MGI platform) + MLPA/Array CGH if indicated | Sanger sequencing only |
| Speed | 3โ4 Weeks | 4โ6 Weeks (limited throughput) |
Physician Insight & Safety Protocols
Clinical Note from Lina Osama Zaki Quteineh (Consultant Medical Genetics, DHA ID 9294403): โThe IGHMBP2 NGS test provides critical molecular confirmation for hereditary motor neuropathy, enabling precise prognostication and genetic counseling. However, a negative result does not exclude other forms of inherited neuropathy, and clinical correlation with EMG/NCS and neurological evaluation remains essential.โ
Advisory Notice
Do not discontinue prescribed medication without consulting your doctor. This test does not replace ongoing neurological management.
Exclusion Criteria & Urgent Red Flags
- Acute respiratory distress or rapidly progressive weakness requiring urgent medical attention โ proceed immediately to the nearest emergency department.
- Inability to provide a blood sample due to severe coagulopathy or active infection.
- Prior allogeneic bone marrow transplant may interfere with germline genetic testing.
- This test is not suitable for somatic mutation detection or pharmacogenomics.
Patient FAQ & Clinical Guidance
1. What does the IGHMBP2 gene test detect and how long do results take?
Snippet: This NGS detects single nucleotide variants, small indels, and copy number changes across the entire IGHMBP2 gene to confirm distal hereditary motor neuropathy type 6 or SMARD1.
The analysis covers all coding exons and splice sites. Results are typically available within 3 to 4 weeks from sample receipt due to comprehensive quality control and confirmatory Sanger sequencing.
2. Is home sample collection available across the UAE?
Snippet: Yes, our ISO-certified phlebotomy team offers hospital-grade home collection throughout Dubai, Abu Dhabi, Sharjah, and all emirates from 8 AM to 11 PM.
A trained phlebotomist arrives with a temperature-controlled transport kit to ensure sample stability. You can schedule via WhatsApp at +971 54 548 8731 and provide insurance details for direct billing.
3. How is my genetic data protected under UAE law?
Snippet: All genomic data is stored and processed in compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
Your sample and results are de-identified, encrypted, and not shared with third parties without explicit consent. A genetic counseling session is required before testing to ensure informed consent.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates under DHA Facility License No. 1143 and strictly complies with:
- Data Protection: Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL).
- Health ICT Law: Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Medical Liability: Federal Decree-Law No. 4 of 2016 on Medical Liability.
All genetic testing is performed with informed consent, and patient data is encrypted, de-identified, and retained only as required by law.
Clinical & Logistical Metadata
| Test Name | IGHMBP2 Gene Distal Hereditary Motor Neuropathy Type 6 (dHMN6/SMARD1) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3โ4 Weeks |
| Sample Type / Matrix | Peripheral Blood (Whole Blood) โ VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection Available (8 AM โ 11 PM daily) |
| Methodology Used | Next-Generation Sequencing (NGS) with Sanger confirmation and CNV analysis |
| ICD-10-CM Code | G60.0 |
| LOINC Code | 21673-8 |
| DHA Facility License & Laboratory Address | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians